Fulgent Genetics Files 8-K for Shareholder Vote
Ticker: FLGT · Form: 8-K · Filed: May 16, 2024 · CIK: 1674930
| Field | Detail |
|---|---|
| Company | Fulgent Genetics, Inc. (FLGT) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: FLGT
TL;DR
Fulgent Genetics is calling for a shareholder vote, get ready for some corporate action.
AI Summary
Fulgent Genetics, Inc. filed an 8-K on May 16, 2024, to report on the submission of matters to a vote of its security holders. The filing indicates that the company is preparing for a shareholder vote, though the specific proposals or outcomes are not detailed in this initial report.
Why It Matters
This filing signals that Fulgent Genetics is engaging its shareholders on important company matters, which could impact corporate governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural, reporting an upcoming shareholder vote without detailing any immediate financial or operational changes.
Key Players & Entities
- Fulgent Genetics, Inc. (company) — Registrant
- May 16, 2024 (date) — Filing date and earliest event reported
- 4399 Santa Anita Avenue El Monte, California 91731 (address) — Principal Executive Offices
- 626-350-0537 (phone_number) — Registrant's telephone number
FAQ
What is the specific purpose of the shareholder vote being reported?
The filing states that it is for the 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals or agenda items in this report.
When was the earliest event reported in this 8-K filing?
The earliest event reported is May 16, 2024, which is also the date of the report.
What is Fulgent Genetics, Inc.'s principal executive office address?
The principal executive offices are located at 4399 Santa Anita Avenue, El Monte, California 91731.
What is the Commission File Number for Fulgent Genetics, Inc.?
The Commission File Number for Fulgent Genetics, Inc. is 001-37894.
Has Fulgent Genetics, Inc. had a former company name?
Yes, the former company name was Fulgent Diagnostics, Inc., with a date of name change on May 17, 2016.
Filing Stats: 600 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-05-16 16:29:29
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share FLGT The Nasdaq Stock Mar
Filing Documents
- flgt-20240516.htm (8-K) — 68KB
- 0000950170-24-061120.txt ( ) — 178KB
- flgt-20240516.xsd (EX-101.SCH) — 24KB
- flgt-20240516_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On May 16, 2024 at 9:00 a.m. Pacific Time, Fulgent Genetics, Inc. (the "Company"), held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"), at the Company's offices at 4399 Santa Anita Avenue, El Monte, California 91731. Of the Company's 29,900,666 shares of common stock issued and outstanding and eligible to vote as of the record date of March 21, 2024, a quorum of 24,480,868 shares, or approximately 82% of the eligible shares, was present in person or represented by proxy. Each of the matters set forth below is described in detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 27, 2024. The following actions were taken at the Annual Meeting: Proposal 1 Election of the following nominees as directors of the Company, each to serve until the 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. Votes For Votes Withheld Broker Non-Vote Ming Hsieh 20,071,185 314,415 4,095,268 Michael Nohaile, Ph.D. 17,462,830 2,922,770 4,095,268 Regina Groves 17,487,701 2,897,899 4,095,268 Linda Marsh 15,854,682 4,530,918 4,095,268 Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained Broker Non-Vote 24,238,701 222,804 19,363 — Proposal 3 Approval, on a non-binding advisory basis, the compensation of the Company's named executive officers. Votes For Votes Against Votes Abstained Broker Non-Vote 19,786,239 573,411 25,950 4,095,268 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 16, 2024 FULGENT G